派博傳思國(guó)際中心

標(biāo)題: Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c [打印本頁]

作者: 調(diào)停    時(shí)間: 2025-3-21 17:46
書目名稱Erythropoietin影響因子(影響力)




書目名稱Erythropoietin影響因子(影響力)學(xué)科排名




書目名稱Erythropoietin網(wǎng)絡(luò)公開度




書目名稱Erythropoietin網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Erythropoietin被引頻次




書目名稱Erythropoietin被引頻次學(xué)科排名




書目名稱Erythropoietin年度引用




書目名稱Erythropoietin年度引用學(xué)科排名




書目名稱Erythropoietin讀者反饋




書目名稱Erythropoietin讀者反饋學(xué)科排名





作者: Consequence    時(shí)間: 2025-3-21 21:07

作者: ILEUM    時(shí)間: 2025-3-22 03:39

作者: Jingoism    時(shí)間: 2025-3-22 05:59
Erythropoietin Synthesis in the Anemic Mouse Kidney as Observed by Morphological Techniques16], the nature of the renal Epo-producing cells is still debated. Immunofluorescence data [10] and glomerular [7] and mesangial [18] culture studies support a glomerular origin of the renal Epo-producing cells. On the other hand an extraglomerular origin of Epo-producing cells, i.e. tubular or inte
作者: 座右銘    時(shí)間: 2025-3-22 09:18

作者: Foreknowledge    時(shí)間: 2025-3-22 12:57
Early Anemia in Mammalses following hypoxia irrespective of the production site of the hormone and decreases when there is a surplus of oxygen-carrying capacity. There are, however, several studies indicating that regulation of erythropoiesis in the neonatal mammal differs from that in the adult [1, 2]. Erythropoiesis in
作者: Foreknowledge    時(shí)間: 2025-3-22 18:28

作者: FLAT    時(shí)間: 2025-3-22 22:31
Erythropoietin Production in Malignancyunterbalances the permanent loss of aged red blood cells. The red cell mass, hemoglobin concentration, and oxygen transport capacity of the blood are relatively constant under physiological conditions. The production of erythropoietin is augmented following phlebotomy, until the mass of red blood ce
作者: Vaginismus    時(shí)間: 2025-3-23 04:21

作者: Axillary    時(shí)間: 2025-3-23 07:31

作者: GENRE    時(shí)間: 2025-3-23 10:43

作者: Detoxification    時(shí)間: 2025-3-23 15:25

作者: 有罪    時(shí)間: 2025-3-23 21:26
Erythropoietin, Blood Viscosity, and Hypertension: Implications for Patients with End-Stage Renal Dicorrecting this anaemia in patients maintained by haemodialysis [1–6]. Up to now, patients have been treated for more than 2 years with sustained benefit and without any evidence of loss of efficacy. Nevertheless, the development or aggravation of hypertension in a certain number of patients treated
作者: Mortar    時(shí)間: 2025-3-23 22:54
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in
作者: Entrancing    時(shí)間: 2025-3-24 04:49

作者: 別炫耀    時(shí)間: 2025-3-24 06:41

作者: mutineer    時(shí)間: 2025-3-24 13:46

作者: 沒有貧窮    時(shí)間: 2025-3-24 16:56
Physiological Studies of Erythropoietin in Plasmad production of the hormone which in turn stimulates the bone marrow to increase the output of new red cells. Thus oxygen delivery is restored to normal. Hyperoxia leads to an increased oxygen supply to the sensor with decreased production of EPO (Fig. 1).
作者: 笨拙的你    時(shí)間: 2025-3-24 20:47

作者: HATCH    時(shí)間: 2025-3-25 02:15
Erythrocytosis in Renal Graft Recipientsovercome their anemic state; their hematocrits once again begin to build up to become normal or close to normal [6, 7]. However, in some patients the hematocrit continues to rise even after complete correction of anemia, resulting in post-transplant erythrocytosis (PTE) [6–9].
作者: Obsequious    時(shí)間: 2025-3-25 07:21

作者: 微不足道    時(shí)間: 2025-3-25 08:58
Erythropoietin, Blood Viscosity, and Hypertension: Implications for Patients with End-Stage Renal Dior cardiovascular disease [8]. The present review considers our current knowledge of the relationships between hypertension, blood rheology, and haematocrit as well as the implication of hypertension as a risk factor for cardiovascular disease.
作者: carbohydrate    時(shí)間: 2025-3-25 11:48
ntrol the differentiation of the pluripotent stem cells. The glycoprotein hormone erythropoietin stimulates the proliferation and differentiation of progenitor cells committed to the erythrocytic lineage (Fig. 1).
作者: 組成    時(shí)間: 2025-3-25 18:31

作者: PRO    時(shí)間: 2025-3-25 23:04
ialysis, the widespread use of this exciting treatment can be expected shortly. However, because of the high treatment costs, attention is beginning to be focused on the impact that partial correction of anemia will have on dialysis therapy in general. The major issue is certainly the potential improvement of quality of life.
作者: Interferons    時(shí)間: 2025-3-26 03:59
Introduction: Advances in Erythropoietin Researchntrol the differentiation of the pluripotent stem cells. The glycoprotein hormone erythropoietin stimulates the proliferation and differentiation of progenitor cells committed to the erythrocytic lineage (Fig. 1).
作者: 初學(xué)者    時(shí)間: 2025-3-26 04:18
Erythropoietin Production Under Steady-State Conditions: Detection and Localization Using In Situ Hyployed for this purpose. From these investigations however, a more important, but overlooked, observation is now also clear; little or no erythropoietin production occurs in the kidney under normal, steady-state conditions [2–9].
作者: 破裂    時(shí)間: 2025-3-26 11:37
Clinical Effects of Partial Correction of Anemia Using Recombinant Human Erythropoietin on Working Cialysis, the widespread use of this exciting treatment can be expected shortly. However, because of the high treatment costs, attention is beginning to be focused on the impact that partial correction of anemia will have on dialysis therapy in general. The major issue is certainly the potential improvement of quality of life.
作者: 施魔法    時(shí)間: 2025-3-26 15:34

作者: OATH    時(shí)間: 2025-3-26 19:32
Ecological and Environmental Impactd production of the hormone which in turn stimulates the bone marrow to increase the output of new red cells. Thus oxygen delivery is restored to normal. Hyperoxia leads to an increased oxygen supply to the sensor with decreased production of EPO (Fig. 1).
作者: 不能平靜    時(shí)間: 2025-3-26 22:29

作者: Cpap155    時(shí)間: 2025-3-27 02:24
Hukou Reform for the New Century,overcome their anemic state; their hematocrits once again begin to build up to become normal or close to normal [6, 7]. However, in some patients the hematocrit continues to rise even after complete correction of anemia, resulting in post-transplant erythrocytosis (PTE) [6–9].
作者: 外星人    時(shí)間: 2025-3-27 07:44
Erythropoietin Synthesis in the Anemic Mouse Kidney as Observed by Morphological Techniques and control mouse kidney, using electron microscopy and immuno-histochemistry. The distribution of the Epo-producing cells within the kidney was assessed by morphometric analysis of the hybridized sections.
作者: Medicare    時(shí)間: 2025-3-27 11:58

作者: ILEUM    時(shí)間: 2025-3-27 16:12

作者: 起波瀾    時(shí)間: 2025-3-27 18:07

作者: Blasphemy    時(shí)間: 2025-3-28 00:48

作者: 發(fā)出眩目光芒    時(shí)間: 2025-3-28 03:51

作者: Inscrutable    時(shí)間: 2025-3-28 08:08

作者: correspondent    時(shí)間: 2025-3-28 14:07
the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
作者: sultry    時(shí)間: 2025-3-28 14:41
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
作者: 賭博    時(shí)間: 2025-3-28 21:48
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
作者: Tremor    時(shí)間: 2025-3-28 23:15

作者: STRIA    時(shí)間: 2025-3-29 06:10

作者: 功多汁水    時(shí)間: 2025-3-29 07:17

作者: overrule    時(shí)間: 2025-3-29 14:54
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
作者: 小故事    時(shí)間: 2025-3-29 17:50
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
作者: malapropism    時(shí)間: 2025-3-29 20:51

作者: 尊重    時(shí)間: 2025-3-30 02:50

作者: Extricate    時(shí)間: 2025-3-30 07:07
Overview: 978-3-642-83747-0978-3-642-83745-6
作者: 一回合    時(shí)間: 2025-3-30 09:43
http://image.papertrans.cn/e/image/315094.jpg
作者: GRAIN    時(shí)間: 2025-3-30 13:00
https://doi.org/10.1007/978-3-642-83745-6anemia; blood; cells; chemistry; clinical trial; pathophysiology; physiology; research
作者: Negotiate    時(shí)間: 2025-3-30 17:42
acity to selfreplicate and to produce progeny committed to any of the different lineages of blood cells. Little is known about the mechanisms which control the differentiation of the pluripotent stem cells. The glycoprotein hormone erythropoietin stimulates the proliferation and differentiation of p
作者: IRK    時(shí)間: 2025-3-30 23:53
Modern China and International Economic Law. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assa
作者: Thyroid-Gland    時(shí)間: 2025-3-31 01:32
tiated by molecular biology techniques [2–8]. Northern transfer analysis with DNA [2–6, 8] and RNA [7] probes, and in situ hybridization [7–9] were employed for this purpose. From these investigations however, a more important, but overlooked, observation is now also clear; little or no erythropoiet




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
牙克石市| 赣榆县| 自治县| 社旗县| 滁州市| 夏河县| 璧山县| 铜川市| 格尔木市| 宁强县| 木兰县| 敖汉旗| 乐清市| 北安市| 怀安县| 镇康县| 南阳市| 明光市| 贵定县| 安丘市| 图片| 榕江县| 视频| 博罗县| 同江市| 织金县| 铁力市| 巫溪县| 临泽县| 无锡市| 休宁县| 远安县| 武山县| 阿荣旗| 桦川县| 繁峙县| 正蓝旗| 于都县| 诏安县| 垦利县| 陕西省|